16-Mar-16 Prenetics, a precision medicine company focused on personalized, predictive and preventive treatments, has announced a USD10 mn strategic investment led by China's Ping An Ventures. Other investors include Indonesia's Lippo Group backed Venturra Capital, Capital Union Investments and existing investors 500 Startups, COENT Venture Partners. [image: Prenetics]

08-Mar-16 According to a circular issued by China's State Council, generic drugs already available on the market should be assessed on whether they are consistent with brand-name drugs, and if they could be used clinically. Crucially, generics that pass the assessment will be included under national insurance coverage. [image: People's Daily Online]

29-Feb-16 An agreement worth RMB10 bn (USD1.5 bn) has been signed between WuXi AppTec and Ping An Bank jointly to explore the health industry. According to the deal, Ping An will provide a credit line for WuXi AppTec to promote the pharmaceutical platform company's development in the domestic market. [image: Chinatopix / Getty Images]

29-Feb-16 The Japanese External Trade Organization (JETRO), which has set a foreign direct investment target of USD300 bn by 2020, is now wooing Indian pharmaceutical companies to maximize its conducive research-innovation ecosystem and advanced manufacturing infrastructure. To this end Japan has amended the Pharmaceutical Affairs Act, drastically improving the approval process for medicine and medical devices. [image: JETRO]

 Webinars